Monoclonal Antibodies in Veterinary Health Market Size, Share & Trends Analysis Report By Type Of Animal (Companion Animals, Livestock), By Application (Dermatology, Pain, Others), By End-User (Veterinary Hospitals, Others), By Region, And By Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Monoclonal Antibodies Market Snapshot Chapter 4. Global Monoclonal Antibodies Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034 4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.9. Use/impact of AI on Monoclonal Antibodies Market Industry Trends 4.10. Global Monoclonal Antibodies Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034 Chapter 5. Monoclonal Antibodies Market Segmentation 1: By Type of Animal, Estimates & Trend Analysis 5.1. Market Share by Type of Animal, 2024 & 2034 5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Animal: 5.2.1. Companion Animals 5.2.2. Livestock Animals Chapter 6. Monoclonal Antibodies Market Segmentation 2: By Application Area, Estimates & Trend Analysis 6.1. Market Share by Application Area, 2024 & 2034 6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application Area: 6.2.1. Dermatology 6.2.2. Pain 6.2.3. Other Application Areas Chapter 7. Monoclonal Antibodies Market Segmentation 4: By End User, Estimates & Trend Analysis 7.1. Market Share by End User, 2024 & 2034 7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User: 7.2.1. Veterinary Hospitals 7.2.2. Other End Users Chapter 8. Monoclonal Antibodies Market Segmentation 5: Regional Estimates & Trend Analysis 8.1. Global Monoclonal Antibodies Market, Regional Snapshot 2024 & 2034 8.2. North America 8.2.1. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.2.1.1. US 8.2.1.2. Canada 8.2.2. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034 8.2.3. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 8.2.4. North America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034 8.3. Europe 8.3.1. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.3.1.1. Germany 8.3.1.2. U.K. 8.3.1.3. France 8.3.1.4. Italy 8.3.1.5. Spain 8.3.1.6. Rest of Europe 8.3.2. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034 8.3.3. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 8.3.4. Europe Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034 8.4. Asia Pacific 8.4.1. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.4.1.1. India 8.4.1.2. China 8.4.1.3. Japan 8.4.1.4. Australia 8.4.1.5. South Korea 8.4.1.6. Hong Kong 8.4.1.7. Southeast Asia 8.4.1.8. Rest of Asia Pacific 8.4.2. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034 8.4.3. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 8.4.4. Asia Pacific Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034 8.5. Latin America 8.5.1. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034 8.5.1.1. Brazil 8.5.1.2. Mexico 8.5.1.3. Rest of Latin America 8.5.2. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034 8.5.3. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 8.5.4. Latin America Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034 8.6. Middle East & Africa 8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 8.6.1.1. GCC Countries 8.6.1.2. Israel 8.6.1.3. South Africa 8.6.1.4. Rest of Middle East and Africa 8.6.2. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Type of Animal, 2021-2034 8.6.3. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by Application Area, 2021-2034 8.6.4. Middle East & Africa Monoclonal Antibodies Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. Boehringer Ingelheim GmbH 9.2.1.1. Business Overview 9.2.1.2. Key Type of Animal/Type of Animal Overview 9.2.1.3. Financial Performance 9.2.1.4. Geographical Presence9.2.1.5. Recent Developments with Business Strategy 9.2.2. Elanco 9.2.3. Indian Immunologicals 9.2.4. Merck 9.2.5. Virbac 9.2.6. Zoetis 9.2.7. adivo GmbH (Part of Zoetis), 9.2.8. Bayer Animal Health 9.2.9. Invetx, 9.2.10. Kindred Biosciences, Inc. 9.2.11. Other prominent players